These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3490912)

  • 1. Non-human primate (baboon) anti-gross cystic disease fluid protein-15 antibody infusion in four women with metastatic breast carcinoma.
    Estabrook A; Kister SJ; Hardy MA; Grossbard L; Oster MW; Davis S; Mazoujian G; Haagensen DE
    Cancer Immunol Immunother; 1986; 23(2):143-7. PubMed ID: 3490912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma. A phase I study.
    Huberman MS; Lokich JJ; Hill T; Kaldany A; Kassis A; Price T; Moore C; Davis S; Kasulis P; Monaco AP
    Cancer Immunol Immunother; 1986; 23(2):137-42. PubMed ID: 3490911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I treatment of women with metastatic breast cancer with baboon anti-gross cystic disease fluid protein.
    Estabrook A; Kister SJ; Hardy MA; Grossbard L; Oster MW; Davis S; Mazoujian G; Haagenson DE
    Curr Surg; 1984; 41(5):375-8. PubMed ID: 6488876
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma.
    Dilley WG; Leight GS; Silva JS; Ammirata S; Haagensen DE; Wells SA
    J Natl Cancer Inst; 1983 Jan; 70(1):69-74. PubMed ID: 6571924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
    Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
    Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
    Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
    Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.
    Dilley WG; Haagensen DE; Leight GS; Ammirata S; Davis SR; Silva JS; Zamcheck N; Lokich JJ; Wells SA
    Breast Cancer Res Treat; 1986; 8(3):205-15. PubMed ID: 3593986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of hormonal therapy in patients with metastatic breast carcinoma by plasma marker protein profiles.
    Haagensen DE; Dilley WG; Cox CE; Giannola JE; Wells SA
    Surg Forum; 1978; 29():162-4. PubMed ID: 401123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
    Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
    Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
    Selim AA; El-Ayat G; Wells CA
    Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver.
    Akasofu M; Kawahara E; Kurumaya H; Nakanishi I
    Acta Pathol Jpn; 1993 Dec; 43(12):736-44. PubMed ID: 7509105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.
    Cassoni P; Sapino A; Haagensen DE; Naldoni C; Bussolati G
    Int J Cancer; 1995 Jan; 60(2):216-20. PubMed ID: 7829219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia.
    Caputo E; Autiero M; Mani JC; Basmaciogullari S; Piatier-Tonneau D; Guardiola J
    Int J Cancer; 1998 Sep; 78(1):76-85. PubMed ID: 9724097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein.
    Haagensen DE; Gall SA; Brazy JE; Giannola J; Wells SA
    Am J Obstet Gynecol; 1980 Sep; 138(1):25-32. PubMed ID: 7416203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Drago J; Rohner T; Haagensen D; Glode M; Santner SJ
    Anticancer Res; 1984; 4(3):141-4. PubMed ID: 6380398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic clearance and metabolism in the rat of a human breast cancer associated glycoprotein (GCDFP-15).
    Toth CA; Haagensen DE; Davis S; Zamcheck N; Thomas P
    Breast Cancer Res Treat; 1988 Oct; 12(2):235-43. PubMed ID: 3242652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium.
    Mazoujian G; Warhol MJ; Haagensen DE
    Am J Pathol; 1984 Aug; 116(2):305-10. PubMed ID: 6205595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma.
    Haagensen DE; Kister SJ; Panick J; Giannola J; Hansen HJ; Wells SA
    Cancer; 1978 Sep; 42(3 Suppl):1646-52. PubMed ID: 709529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.